AI assistant
Sending…
Immunome Inc. — Director's Dealing 2025
Dec 22, 2025
32238_dirs_2025-12-22_d957fd7f-fdf1-4a42-a82c-bb0d59306533.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Immunome Inc. (IMNM)
CIK: 0001472012
Period of Report: 2025-12-19
Reporting Person: Tsai Philip (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-19 | Common Stock | P | 10000 | $20.49 | Acquired | 43300 | Direct |
More from Immunome Inc.
Annual Report
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 24
Regulatory Filings
2026
Mar 20
Annual Report
2026
Mar 3
Regulatory Filings
2026
Mar 3
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2025
Dec 31
Director's Dealing
2025
Dec 23
Major Shareholding Notification
2025
Dec 23